-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Alzheimer's disease (Alzheimer's Disease, AD) early biomarkers not only contribute to the early recognition of AD, but also can be used as new drug targets and pharmacodynamic evaluation indicators
Age is the main risk factor for AD
Because AEP is widely present in the brain and liver, kidney, pancreas, spleen and other organs, the content of AEP in peripheral body fluids cannot reflect the changes of AEP in the brain.
Three master students including Wang Shanshan of Shanghai Jiaotong University School of Medicine are the co-first authors of the paper.